ArticleBioinformatics (Oxford, England)2026
NanoSimFormer: an end-to-end transformer-based nanopore signal simulator with basecaller guidance.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationHigh-fidelity simulation of nanopore sequencing signals is critical for rigorous benchmarking and validation of the nanopore signal processing pipeline. However, existing signal simulators often fail to capture the non-linear dynamics of nanopore current signals, relying on static pore models or lacking optimization objectives tied to basecalling, resulting in synthetic signals with low basecalling accuracy and fidelity.
resultsWe introduce NanoSimFormer, an end-to-end Transformer-based signal simulator that integrates basecaller guidance during training to generate high-fidelity nanopore signals. NanoSimFormer achieves a median basecalling accuracy exceeding 99% and Q-scores above 22.8 for Oxford Nanopore Technologies' latest DNA R10.4.1 and direct RNA sequencing, closely mirroring real experimental baselines. It faithfully recapitulates experimental variant calling performance across the five human samples, achieving F1-scores of 0.9953-0.9973 and 0.7862-0.8612 for single-nucleotide polymorphisms and small indels detections, respectively. Compared with previous simulators, NanoSimFormer also substantially reduces false positives in homopolymer and short tandem repeat regions. NanoSimFormer-derived reads enable high-quality de novo bacterial assembly with consensus error rates below one mismatch per 100 kbp and maintain high correlations with experimental abundance in metagenomic and transcriptomic datasets. AVAILABILITY AND IMPLEMENTATION: NanoSimFormer is freely available on GitHub at: https://github.com/BioinfoSZU/NanoSimFormer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.